Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group
- Ann S Knoop
- , Helle Knudsen
- , Eva Balslev
- , Birgitte B Rasmussen
- , Jens Overgaard
- , Kirsten V Nielsen
- , Andreas Schonau
- , Katrín Gunnarsdóttir
- , Karen E Olsen
- , Henning Mouridsen
- , Bent Ejlertsen
- , Danish Breast Cancer Cooperative Group
301
Citationer
(Scopus)